Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1Phase 1 1

Status

Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 3978Pancreatic Neoplasms 2479Carcinoma, Hepatocellular 2413Stomach Neoplasms 2109Rectal Neoplasms 1676Colonic Neoplasms 1629Esophageal Neoplasms 1312Liver Neoplasms 878Neoplasms 633Breast Neoplasms 596Cholangiocarcinoma 525Gastrointestinal Neoplasms 468Neoplasm Metastasis 456Esophageal Squamous Cell Carcinoma 434Lung Neoplasms 422Biliary Tract Neoplasms 277Prostatic Neoplasms 270Ovarian Neoplasms 235Barrett Esophagus 224Adenocarcinoma Of Esophagus 202Gallbladder Neoplasms 191Head and Neck Neoplasms 185Carcinoma, Non-Small-Cell Lung 185Gastrointestinal Stromal Tumors 180Anus Neoplasms 179Recurrence 168Melanoma 162Adenocarcinoma 156Uterine Cervical Neoplasms 153Bile Duct Neoplasms 153

Interventions

Exercise 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Colon Cancer Prevention × Gastrointestinal × Clear all
NCT07328308 2026-01-09

Delayed Surveillance Colonoscopy Following Piecemeal EMR

Rambam Health Care Campus

Phase NA Not yet recruiting
760 enrolled
Gastrointestinal

Colon Cancer Prevention

NCT03148119 2018-04-24

Study of QRH-882260 Heptapeptide Application in the Colon

University of Michigan

Phase 1 Terminated
5 enrolled
Gastrointestinal

Colon Cancer Prevention

NCT00668161 2012-11-28

APPEAL

Fred Hutchinson Cancer Center

Phase 2/3 Completed
202 enrolled
Gastrointestinal

Colon Cancer Prevention

Data powered by HemOnc (CC BY 4.0) Colophon âš¡